Digg It - Internet and Businesses Online

I started noticing that my Adsense earnings were falling like a stone about 3 month

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s ago. I am no guru, but for sometime now I've really valued my Adsense checks that

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

usually arrive by special courier.

My Adsense income comes in through a couple of

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

logs that I run. Usually I drive free traffic to them using free keyword rich artic

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

es I write myself and nothing else. With this kind of arrangement, Google Adsense h

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s been pretty profitable for me.

So you can understand my pain when my Adsense inc

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ome went Ka-boom all of a sudden without any warning.

At first I figured that ther

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

had to be some changes Google had made (they are always making changes aren't they

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

) and I promised myself that I would somehow figure it out. Instead my earnings con

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

inued their free fall. Last month they hit rock bottom and I have now been busy try

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ng to see how best to go back to some of my old haunts with my hat humbly in hand.

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

Then last week, totally by accident I stumbled onto some information online and ev

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rything fell into place. The mystery was explained. The reason why my earnings had

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

uddenly crashed without any warning. The reason why my clicks were on the increase

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

nd yet I never seemed to earn more than a few miserable cents for any single misera

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

le click.

I read Part I of the report and caught by breath for a minute staring at

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

my computer screen in utter disbelief. The special report that I had stumbled into

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

online talks about a site whose earnings had dropped from $30,000 a month to less t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

an $5,000 a month, just like that. And those were the big boy gurus, what chance di

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

small operators like me now stand?

"What was I going to do?" I kept asking myself

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/73549/diggit-The-Death-Of-Adsense-Have-Your-Earnings-Hit-Rock-Bottom-In-Recent-Months.html">The Death Of Adsense: Have Your Earnings Hit Rock Bottom In Recent Months?</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/73549/diggit-The-Death-Of-Adsense-Have-Your-Earnings-Hit-Rock-Bottom-In-Recent-Months.html]The Death Of Adsense: Have Your Earnings Hit Rock Bottom In Recent Months?[/url]

Fundraisng for Charity can be very gratifying. The are basic requirements that should be met to insure a successful fundraiser. These requirements can be learned with ease and commitment.

What can managers do to turn around negative employee attitudes? By taking proactive leader action, managers can combat negative attitudes that damage productivity, and affect the morale of all employees.

As we saw in the first part of our series, there are a many benefits of using Google AdWords when starting to use online marketing tools to grow your business. Now, let's continue our look at how to use the power of AdWords to see what your competitors are up to.

Tags

Links

Digg It - The Death Of Adsense: Have Your Earnings Hit Rock Bottom In Recent Months?

Related Articles: